Overview

Local Paclitaxel Delivery for SFA Disease

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
To see if restenosis rates of superficial femoral artery atherosclerosis with percutaneous techniques can be improved using paclitaxel.
Phase:
N/A
Details
Lead Sponsor:
University of Oklahoma
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel